VYNE Therapeutics
VYNE
VYNE
44 hedge funds and large institutions have $4.77M invested in VYNE Therapeutics in 2025 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
9.12% more ownership
Funds ownership: 15.61% → 24.73% (+9.1%)
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$512K | |
| 2 | +$454K | |
| 3 | +$401K | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$102K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$77.1K |
Top Sellers
| 1 | -$285K | |
| 2 | -$235K | |
| 3 | -$30K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$25.8K |
| 5 |
CCM
Corsair Capital Management
New York
|
-$16.8K |
